---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-011327"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T08:10:58.454845+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Provectus Biopharmaceuticals Names Dominic Rodrigues Principal Executive Officer; Bruce Horowitz Resigns

## Summary
- Bruce Horowitz resigned as COO and Director on March 25, 2024, and entered a termination agreement with a total payment of up to $750,000.
- The termination agreement includes an initial $250,000 payment and a second payment of $258,000 if paid before June 30, 2024, otherwise $500,000.
- Dominic Rodrigues was appointed as chief operations consultant and principal executive officer with a monthly fee of $20,000.
- The company agreed to continue D&O insurance for Horowitz for two years and Horowitz agreed to a five-year standstill.
- The termination agreement includes mutual releases, confidentiality reaffirmation, and non-disparagement.

## SEC filing metadata
- accession: 0001493152-24-011327
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000149315224011327/0001493152-24-011327-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000149315224011327/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-011327
- JSON: https://secwatch.observer/filing/0001493152-24-011327.json
- Plain text: https://secwatch.observer/filing/0001493152-24-011327.txt

## Key facts
- Executive change
  Dominic Rodrigues was appointed as Chief Operations Consultant at PROVECTUS BIOPHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Chief Operations Consultant
  source text: the Board retained Dominic Rodrigues as the Company’s chief operations consultant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/315545/000149315224011327/0001493152-24-011327-index.htm
- Executive change
  Bruce Horowitz resigned as Chief Operating Officer at PROVECTUS BIOPHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: On March 25, 2024, Bruce Horowitz resigned from the Board of Directors (the “Board”) of Provectus Biopharmaceuticals, Inc. (the “Company”) and as the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/315545/000149315224011327/0001493152-24-011327-index.htm
- Executive change
  Bruce Horowitz resigned as Director at PROVECTUS BIOPHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Director
  source text: On March 25, 2024, Bruce Horowitz resigned from the Board of Directors (the “Board”) of Provectus Biopharmaceuticals, Inc. (the “Company”) and as the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/315545/000149315224011327/0001493152-24-011327-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.